Cleave Biosciences Lands $10,000,000 Series A Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b1a01177-c3fe-40a7-a877-8f56766150b1&Preview=1
Date
4/9/2013
Company Name
Cleave Biosciences
Mailing Address
866 Malcolm Burlingame, CA 94010
Company Description
The big idea at Cleave is to develop small-molecule chemical compounds that will interact with certain protein pathways that get thrown out of whack in patients with cancer.
Website
http://www.cleavebio.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,000
Transaction Round
Series A
Proceeds Purposes
Cleave will use the funds to move its lead program into clinical trials and advance its second discovery program.
M&A Terms
Venture Investor
New Enterprise Associates